C4 Therapeutics, Inc. (CCCC)
2.43
-0.04
(-1.62%)
USD |
NASDAQ |
Dec 15, 16:00
2.40
-0.03
(-1.23%)
Pre-Market: 08:52
C4 Therapeutics Total Liabilities (Quarterly): 111.08M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Biogen, Inc. | 11.00B |
| Amicus Therapeutics, Inc. | 638.39M |
| GT Biopharma, Inc. | 1.321M |
| Nurix Therapeutics, Inc. | 150.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.49M |
| Shareholders Equity (Quarterly) | 154.41M |
| Debt to Equity Ratio | 0.3981 |
| Current Ratio | 5.755 |
| Net Debt Paydown Yield | 0.84% |